RxDoctor Payments Data

Thomas Suchy, MD

Interventional Pain Medicine · Buffalo, NYNPI 1477999456

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $19,894 of the $28,837 with a category attached, or 69.0%. Abbott accounts for 63.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2024 at $8,842 and has fallen 80.2% since, to $1,750 in 2025. Among interventional pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,837in general payments, 2019–2025

Across 602 payments — averaging $47.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Nevro Corp.$3K
  • Relievant Medsystems, Inc.$1K
  • Boston Scientific$1K
  • Vertos Medical, Inc.$1K
  • Globus Medical$650
  • plus $3K from 24 others

What the payments were for

  • Speaking & faculty fees$5,63120%
  • Travel & lodging$3,31211%
  • Food & beverage$19,89469%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,837 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$24,854
Medicare patients
85
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin15$186
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$88

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →